Bell Investment Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Bell Investment Advisors's BIIB Position: Q2 2026 in Review
Bell Investment Advisors increased its Biogen (BIIB) stake by 2.4% in Q2 2026, buying an estimated $574 and bringing the position to 127 shares worth $27.4K. The position accounts for ﹤0.01% of the portfolio, ranked #399.
Bell Investment Advisors first reported a position in BIIB in Q3 2021 and has held it in 18 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Bell Investment Advisors held 127 shares of Biogen worth $27.4K as of Q2 2026.
- Bell Investment Advisors bought 3 Biogen shares in Q2 2026, an estimated $574.
- Biogen made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #399 holding.
- Bell Investment Advisors first reported a position in Biogen in Q3 2021 and has held it in 18 quarters since.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.